Announcements Trials
Browse Landscape

Phase

Phase 1 2

Status

Terminated 1Recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 21Head & Neck 5Breast 5Thoracic 4Gastrointestinal 4Sarcoma 3Lymphoid 2Gynecologic 2Dermatologic 2Other solid neoplasm 1Myeloid 1CNS 1

Conditions

Melanoma 339Carcinoma, Non-Small-Cell Lung 79Skin Neoplasms 69Carcinoma, Renal Cell 49Lung Neoplasms 48Neoplasm Metastasis 46Breast Neoplasms 45Colorectal Neoplasms 42Carcinoma, Basal Cell 42Neoplasms 41Uveal Melanoma 37Squamous Cell Carcinoma of Head and Neck 37Carcinoma, Merkel Cell 35Ovarian Neoplasms 34Lymphoma, T-Cell, Cutaneous 31Sarcoma 30Pancreatic Neoplasms 25Prostatic Neoplasms 24Carcinoma, Hepatocellular 21Head and Neck Neoplasms 20Uterine Cervical Neoplasms 19Urinary Bladder Neoplasms 19Thyroid Neoplasms 19Stomach Neoplasms 19Esophageal Neoplasms 17Carcinoma, Squamous Cell 17Brain Neoplasms 17Mycosis Fungoides 16Triple Negative Breast Neoplasms 15Recurrence 15

Interventions

Gemcitabine 1Etoposide 1Cyclophosphamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Urologic Neoplasms × Dermatologic × 90 days × Clear all
NCT03093909 2026-05-20

Study of Aerosol Gemcitabine in Patients With Solid Tumors and Pulmonary Metastases

M.D. Anderson Cancer Center

Phase 1 Recruiting
44 enrolled
DermatologicGenitourinarySarcoma

Bone Neoplasms, Melanoma, Osteosarcoma, Urologic Neoplasms

NCT03420963 2026-03-20

Donor Natural Killer Cells, Cyclophosphamide, and Etoposide in Treating Children and Young Adults With Relapsed or Refractory Solid Tumors

M.D. Anderson Cancer Center

Phase 1 Terminated
12 enrolled
DermatologicGenitourinaryHead & NeckOther solid neoplasmSarcomaThoracic

Mesothelioma, Malignant, Bone Neoplasms, Endocrine Gland Neoplasms, Melanoma, Mouth Neoplasms, Pharyngeal Neoplasms, Sarcoma, Skin Neoplasms, Thyroid Neoplasms, Urologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡